CASI Pharmaceuticals Inc (NASDAQ:CASI) moved up about 9.22% on strong volume last week and it looks like a lot of traders booked gains from the upwards run, but I did exactly the opposite. With the resistance level already identified on the charts and with the huge insider activity revealed, I used the pullback to take a big long position. Usually when insiders...
CASI saw a nice bump in after-hours trading Friday. Shares hit $1.88. Can the Oppenheimer analyst rating be enough of a catalyst to carry through this momentum into the week ahead is the biggest question. Great volume on Friday but is it all for nothing?
"What had sparked some excitement came in light of new analyst activity. Oppenheimer analyst Leland Gershell...
openinsider. com/search?q=CASI
insider BUY
CASI Zhang Larry Pres P - Purchase $1.90 +20,153 20,153 New +$38,291
CASI He Wei-Wu COB, CEO, 10% P - Purchase $1.90 +4,152,426 12,809,942 +48% +$7,889,609
Yahoo finance “CASI Pharmaceuticals Inc (CASI), a biopharmaceutical company dedicated to developing high-quality products and therapeutics to the global health market, announced earlier this month that it had received National Medical Products Administration approval of Melphalan Hydrochloride For Injection.
CASI Pharmaceuticals Executive Chairman Wei-Wu He,...
Market retreats to 20 period EMA after making new highs (for long positions)/lows (for shorts) with ADX (14period) >30. Some people use the 20 period SMA . Projection is a retest of the highs. Trailing stop. ***Failed grails tend to move (painfully) in the opposite direction.
Setup invalid below weekly EMA (5.73)
CASI has broken the last upward move, so it's possible to see more downside, with a potential test on the previous low. Finished this retrace i'm expecting a strong wave up.
